Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia
Jean‐Philippe Krieger, Myrtha Arnold, Klaus G. Pettersen, et al.
Diabetes (2015) Vol. 65, Iss. 1, pp. 34-43
Open Access | Times Cited: 222

Showing 1-25 of 222 citing articles:

Glucagon-like peptide 1 (GLP-1)
Timo D. Müller, Brian Finan, Stephen R. Bloom, et al.
Molecular Metabolism (2019) Vol. 30, pp. 72-130
Open Access | Times Cited: 1308
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
Cell Metabolism (2018) Vol. 27, Iss. 4, pp. 740-756
Open Access | Times Cited: 1242
Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit
Zhuang Li, Chun‐Xia Yi, Saeed Katiraei, et al.
Gut (2017) Vol. 67, Iss. 7, pp. 1269-1279
Open Access | Times Cited: 552
Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB
Robert E. Steinert, Christine Feinle‐Bisset, Lori Asarian, et al.
Physiological Reviews (2016) Vol. 97, Iss. 1, pp. 411-463
Open Access | Times Cited: 489
Anxiety, Depression, and the Microbiome: A Role for Gut Peptides
Gilliard Lach, Harriët Schellekens, Timothy G. Dinan, et al.
Neurotherapeutics (2017) Vol. 15, Iss. 1, pp. 36-59
Open Access | Times Cited: 489
GLP-1 physiology informs the pharmacotherapy of obesity
Daniel J. Drucker
Molecular Metabolism (2021) Vol. 57, pp. 101351-101351
Open Access | Times Cited: 276
Signaling pathways in obesity: mechanisms and therapeutic interventions
Xue Wen, Bohan Zhang, Beiyi Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 244
A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism
E. Grasset, Anthony Puel, J. Charpentier, et al.
Cell Metabolism (2017) Vol. 25, Iss. 5, pp. 1075-1090.e5
Open Access | Times Cited: 237
Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway
Paige V. Bauer, Frank A. Duca, T.M. Zaved Waise, et al.
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 101-117.e5
Open Access | Times Cited: 227
Role of the vagus nerve in the development and treatment of diet‐induced obesity
Guillaume de Lartigue
The Journal of Physiology (2016) Vol. 594, Iss. 20, pp. 5791-5815
Open Access | Times Cited: 214
Enterochromaffin 5-HT cells – A major target for GLP-1 and gut microbial metabolites
Mari L. Lund, Kristoffer L. Egerod, Maja S. Engelstoft, et al.
Molecular Metabolism (2018) Vol. 11, pp. 70-83
Open Access | Times Cited: 210
Glucose transporters in the small intestine in health and disease
Hermann Koepsell
Pflügers Archiv - European Journal of Physiology (2020) Vol. 472, Iss. 9, pp. 1207-1248
Open Access | Times Cited: 197
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
Brent A. McLean, Chi Kin Wong, Jonathan E. Campbell, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 101-132
Open Access | Times Cited: 196
Central and peripheral GLP-1 systems independently suppress eating
Daniel I. Brierley, Marie K. Holt, Arashdeep Singh, et al.
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 258-273
Open Access | Times Cited: 179
Metabolic Messengers: glucagon-like peptide 1
Fiona M. Gribble, Frank Reimann
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 142-148
Closed Access | Times Cited: 143
Role of the gut–brain axis in energy and glucose metabolism
Hallie Wachsmuth, Savanna N. Weninger, Frank A. Duca
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 377-392
Open Access | Times Cited: 130
The metabolic impact of small intestinal nutrient sensing
Frank A. Duca, T.M. Zaved Waise, Willem T. Peppler, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 128
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, et al.
Pharmacological Research (2022) Vol. 186, pp. 106550-106550
Open Access | Times Cited: 117
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 88
Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review
Manoj K. Mahapatra, Muthukumar Karuppasamy, Biswa Mohan Sahoo
Pharmaceutical Research (2022) Vol. 39, Iss. 6, pp. 1233-1248
Open Access | Times Cited: 71
Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes
Susanna Longo, Stefano Rizza, Massimo Federici
Acta Diabetologica (2023) Vol. 60, Iss. 8, pp. 1007-1017
Open Access | Times Cited: 70
Dissociable hindbrain GLP1R circuits for satiety and aversion
Kuei-Pin Huang, Alisha A Acosta, Misgana Y. Ghidewon, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 585-593
Closed Access | Times Cited: 34
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
When short-chain fatty acids meet type 2 diabetes mellitus: Revealing mechanisms, envisioning therapies
Cong Xie, Cong Qi, Jianwen Zhang, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116791-116791
Open Access | Times Cited: 2
A Hypothesis That Glucagon-like Peptide-1 Receptor Agonists Exert Immediate and Multifaceted Effects by Activating Adenosine Monophosphate-Activate Protein Kinase (AMPK)
C. Mary Schooling, Guoyi Yang, Ghada A. Soliman, et al.
Life (2025) Vol. 15, Iss. 2, pp. 253-253
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top